Dozens of clinics market risky cell therapies to treat eye disorders

  • 📰 ChannelNewsAsia
  • ⏱ Reading Time:
  • 30 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 15%
  • Publisher: 66%

Business News News

Business Business Latest News,Business Business Headlines

(Reuters Health) - - Scores of clinics across the United States directly advertise expensive - but unproven - cell therapy procedures to patients ...

- - Scores of clinics across the United States directly advertise expensive - but unproven - cell therapy procedures to patients with serious eye diseases, often with devastating results, a new study warns.

"Patients have paid anywhere from US$5000 to upwards of US$50,000 per treatment," he added."Patients have been taking out mortgages on their homes to pay for these kinds of treatments." "The proprietors have taken considerable pains to push the boundaries of the guidelines, and in some cases misrepresented registered studies as 'government approved' studies, thereby effectively gaming the system," said Dr. Henry Klassen, professor at the Gavin Herbert Eye Institute at the University of California, Irvine, who wasn't involved in the study.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 6. in BUSİNESS

Business Business Latest News, Business Business Headlines